Skip to content
healthcare.dev

Ondansetron

NDC 71335-2635, Ondansetron, tablet, orally disintegrating, from Bryant Ranch Prepack.

Product NDC
71335-2635
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078152
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2635 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON8 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
71335-2635-0713352635003 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-0)
71335-2635-17133526350130 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-1)
71335-2635-27133526350210 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-2)
71335-2635-3713352635035 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-3)
71335-2635-4713352635044 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-4)
71335-2635-5713352635056 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-5)
71335-2635-67133526350614 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-6)
71335-2635-77133526350760 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-7)
71335-2635-87133526350812 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-8)
71335-2635-97133526350990 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-2635-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40d9cc46-aced-4866-812b-7d82933596ae

Use it

Look up 71335-2635 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2635 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71335-2635. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.